Skip to main content
Research and pharmaceutical organisations operate at the intersection of science, regulation, and commerce. Whether you run a research laboratory, a clinical trials unit, a pharmaceutical manufacturer, or a biotech company, the demands are unique: every experiment must be traceable, every sample accounted for, every regulatory submission documented, and every batch manufactured to exact specification. The stakes in this industry are unusually high. A data integrity failure in a clinical trial can invalidate years of research. A batch release error can lead to product recalls and patient harm. A regulatory submission with missing documentation can delay a product launch by months. The systems that support research and pharma operations must therefore be rigorous, auditable, and precise.

Who Works in Research & Pharma


Common Business Challenges

Data integrity and audit trails. Regulatory bodies (such as FDA and EMA) require that every data point in a study can be traced to its source, every change is recorded, and every result is attributable to a qualified individual. Manual records or unstructured digital systems cannot reliably provide this. Sample traceability. In laboratory operations, samples must be tracked from collection through every processing step, storage condition, and analysis event. Losing chain of custody for a sample can invalidate the entire experiment. Protocol and SOP management. Research activities are governed by approved protocols and standard operating procedures. Ensuring that all staff follow current versions - and that outdated versions are not accidentally used - requires structured document control. Inventory management for controlled substances. Pharmaceutical operations often involve controlled raw materials, reference standards, and investigational products that require precise stock management, usage recording, and periodic reconciliation. Regulatory submission tracking. A pharmaceutical product moving through regulatory approval may require hundreds of documents submitted across multiple agencies, over several years. Tracking submission status, agency queries, and response deadlines manually is a significant risk. Cost tracking across projects. Research organisations often run multiple funded projects simultaneously, each with its own budget, timeline, and reporting requirements. Allocating costs accurately across projects - and reporting to funders - requires structured financial tracking.

How Bizaxl Supports Research & Pharma


Business Lifecycle

A typical research-to-product lifecycle moves through this sequence:
1

Research project initiated

A research project is formally opened with defined objectives, team, and budget.
2

Protocol developed and approved

The study protocol is written, reviewed, and approved before any work begins.
3

Ethics or regulatory approval obtained

The required ethics committee or regulatory approvals are secured.
4

Study materials procured and logged

Reagents, consumables, and investigational materials are sourced and recorded in inventory.
5

Experiment or trial conducted

The study activities are carried out in accordance with the approved protocol.
6

Samples collected and tracked

Samples are collected, labelled, and tracked through the chain of custody.
7

Data recorded and analysed

All observations and measurements are recorded and subjected to analysis.
8

Results documented and reviewed

Findings are documented in study reports and reviewed by the principal investigator.
9

Regulatory submission prepared

The dossier and supporting documentation are compiled for regulatory submission.
10

Submission made and tracked

The submission is filed with the relevant agency and its status is tracked.
11

Agency queries responded to

Any queries or requests for clarification from the agency are addressed and submitted.
12

Product approved

The regulatory agency grants approval for the product.
13

Manufacturing batch initiated

A production batch is initiated using the approved formulation and process.
14

Quality control and release

The batch undergoes quality control testing and is formally released for distribution.
15

Product distributed

The approved and released product is dispatched to the relevant markets or customers.

Coming Soon

Full feature documentation for Research & Pharma is being prepared. Contact support@bizaxl.com for information about your specific implementation.